• No results found

Lysosomal network proteins as biomarkers and therapeutic targets in neurodegenerative disease

N/A
N/A
Protected

Academic year: 2021

Share "Lysosomal network proteins as biomarkers and therapeutic targets in neurodegenerative disease"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Lysosomal network

proteins as biomarkers

and therapeutic targets in

neurodegenerative disease

Linköping University Medical Dissertations No. 1492

Andrea Boman

An

dre

a B

om

an

L

ys

os

om

al n

etw

ork p

ro

te

in

s a

s b

iom

ark

ers a

nd t

he

ra

pe

uti

c t

arg

ets i

n n

eu

ro

de

ge

ne

ra

tiv

e d

ise

as

e

20

15

Faculty of Medicine and Health Sciences

Department of Clinical and Experimental Medicine Linköping University

SE-581 83 Linköping Sweden

References

Related documents

Recently, additional full-length cell culture infectious virus constructs for genotypes 1 and 2 were de- scribed and in addition chimeric genomes encoding geno- types 1 through

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease.. Defining imaging

This population referred to as “ADAM” was found protective during EAE, and loss of this population in the aged mice deficient in microglial ULK1 associated with high mortality,

Taken together, these results underline that: (a) SOAT1 expression in hepatocyte-like cell lines contributes to their distorted lipid and lipoprotein phenotype, (b) the

Accuracy of brain amyloid detec- tion in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross- validation study against amyloid positron emission tomography.. Zwan

The expression analysis of TCGA data suggested that glioblastoma patients with tumors having low PROX1 mRNA levels were enriched for mesenchymal gene expression subtype

[r]

The articles associated with this thesis have been removed for copyright reasons. For more details about